Assurez une sérialisation sans faille de vos médicaments et produits pharmaceutiques ! Disposez enfin de tableaux de bords personnalisés et simple à analyser pour mieux lutter contre la contrefaçon de médicaments ! Mieux visualiser vos données et mieux analyser les alertes et mieux retracer les erreurs grâce à des solutions BI adaptées à l'industrie pharmaceutique ! Une solution adaptée aux besoins et obligations des Laboratoires pharmaceutiques, dépositaires et grossistes répartiteurs...

54 similar entities Type: Startup Activities: it services Technologies: Data Analytics

Vital pharmaceutical industry news and business-critical market and company intelligence for commercial decision makers. Have you got the insight you need to stay at the forefront of today’s market developments? In the fast moving pharmaceutical markets, we know that staying up to date with the latest global trends and talking points is essential for success. It’s not an easy task. With pressure on time and resources, it can be difficult to ensure you have the breadth of market knowledge you need to respond quickly and stay ahead. Scrip, from Informa Group Plc, goes beyond the headlines and focuses on delivering …

59 similar entities Type: SMB Activities: biotech deeptech Technologies: Data Analytics

World leaders, pioneers and advocates in clinically validated, safe and effective #DigitalTherapeutics. We are global pioneers in digital therapeutics, successfully launching our first product in 2001. Our mission is to develop clinically validated digital therapeutics that empower patients, payers, and physicians with effective, FDA cleared products that have the same effect sizes as drugs. Our products are created by our team of multidisciplinary experts, covering all competencies required to develop, launch and maintain top-of-class products for major markets. Our team includes experienced physicians and psychotherapists, clinical scientists experienced in orchestrating Phase II & III trials, IT and software engineers, regulatory …

117 similar entities Type: SMB Activities: healthtech Technologies: Data Analytics

We have a new page! Follow "Citeline, formerly Pharma Intelligence" to stay up to date on all our new posts moving forward as we transition! From drug and device discovery and development to regulatory approval, drug reimbursement to lifecycle management – you need to make smart decisions that give you an advantage in a fast changing market. The pharma and healthcare sector is facing unparalleled upheaval: increasing pressures on research and development teams to show a better return on investment, difficulty keeping abreast of complex regulatory and pricing and reimbursement environments and the race to get the best deal in …

88 similar entities Type: SMB Activities: biotech deeptech Technologies: Data Analytics

Delta4 is a Vienna-based biotech startup driving the forefront of digital drug discovery and development. Delta4 is driving the forefront of digital drug discovery and development. We leverage a proprietary computational analytics platform "Hyper-C", combining straightforward biomedical testing and clinical validation of candidate drugs. Our unique approach integrates iterative big data/in silico and experimental screens, offering the most efficient matching of clinical indications and compound/drug effects. drug repositioning, drug discovery, compounds, orphan diseases, indication expansion, AI, and omics

178 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology

Providing the trusted research and strategic planning services you need for your drug or medical device. RTI Health Solutions'​ integrated project teams are here to help you with your pharmaceutical and medical device research needs. Our robust and trusted methods provide answers to the research questions relevant to your drug or device. Our experienced teams are with you throughout your product's lifecycle to ensure you have the evidence you need when you need it. They continuously monitor your portfolio of projects to keep them flowing seamlessly—enabling you to focus your time elsewhere. Follow us on Bluesky at @rti-hs.bsky.social We are …

117 similar entities Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Making the most innovative therapies possible for everyone. Medios is a leading specialty pharmaceutical company and pioneer of individual medicine. Together with pharmacies, doctors and pharmaceutical companies, we ensure a safe and reliable supply of medicines for complex and serious illnesses. As a pharmaceutical supplier and GMP manufacturer of patient-specific therapies, we connect all relevant players in the healthcare market in a strong network. In this way, we make it possible for specialized medicines to arrive exactly where they are needed. Our focus is on the production and provision of patient-specific therapies as well as an efficient supply structure for …

130 similar entities Type: Startup Activities: healthtech Technologies: Data Analytics

The experts in AI technology for drug discovery and development. Partex.AI technology, founded in 2011, leverages Artificial intelligence, machine learning, and blockchain to revolutionize life sciences. With a portfolio of 190+ US/EU patents, it aggregates and analyzes biomedical data to aid drug discovery, optimize clinical trials, and ensure regulatory compliance. By leveraging its ontology, data and AI models, it accelerates drug development and reduces costs. Committed to innovation and collaboration, it empowers Big Pharma and CROs to bring effective treatments to market efficiently and faster. It is headquartered in Eschborn, Germany, with offices in Pune, India, Iselin and San Francisco, …

131 similar entities Type: Startup Activities: it services Technologies: Blockchain/Cryptocurrency A.I. A.I. - Image Processing A.I. - Machine Learning A.I. - Natural Language Processing Data Analytics

A Sustainable Platform for Specialty Pharma. As a globally operating company headquartered in Germany, CHEPLAPHARM has established a leading and sustainable platform for specialty pharma during the past two decades. We invest worldwide in well-established pharmaceutical brands which have been developed and introduced by research-based pharmaceutical companies. Our deep expertise in this field enables us to sustain the value of these brands for patients and the medical community. In this way we help the research-based pharmaceutical industry divest from older products so they can focus resources on innovation and new product pipelines. This is how we ACHIEVE MORE together. Specialty …

120 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Late clinical stage company focused on drug discovery and development for the treatments of rare disorders of the CNS For additional information: info@sombiotech.com Pre-clinical validation, Licensing, In silico screening, Rare Diseases, Drug repurposing, Orphan CNS indications, Central Nervous System, Intellectual Property, and Artificial Intelligence

288 similar entities Type: Startup Activities: biotech deeptech legaltech Technologies: A.I. Synthetic Biology

Mark Smith and Stephen Cork were appointed Administrators on 21 August 2024, and act without personal liability. Destiny Pharma is a clinical stage, innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections. Its pipeline has novel microbiome-based biotherapeutics and XF drug clinical assets including NTCD-M3, a Phase 3 ready treatment for the prevention of C. difficile infection (CDI) recurrence which is the leading cause of hospital acquired infection in the US and also XF-73 nasal gel, which has recently completed a positive Phase 2b clinical trial targeting the prevention of post-surgical staphylococcal hospital infections …

236 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

LIFE UNLOCKED At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®. DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. Personalized medicine planning and corporate strategy, Comprehensive commercial planning in personalized medicine, Optimizing return on investment in personalized medicine, Leveraging diagnostics to enhance value in personalized medicine, Understanding the diagnostic …

100 similar entities Type: SMB Activities: deeptech Technologies: Data Analytics

Guiding Pharmaceutical and Consumer Healthcare Companies to Success Pharmaceutical and consumer healthcare companies work within dynamic, sometimes unpredictable, regulatory and commercial environments. Pinney Associates' multidisciplinary teams anticipate your scientific and policy obstacles while guiding you toward regulatory and marketplace success. Pharmaceuticals, Risk Management, Abuse Liability Testing, Rx to OTC Switch, In vitro, Abuse potential assessment, Consumer healthcare, Consumer insights, Business development, FDA, CNS active drugs, Regulatory, Over-the-counter medicines, OTCs, Nonprescription drugs, Dietary supplements, Regulatory Strategy, Clinical Development, Eight Factor Analysis 8FA, Abuse Deterrent Formulation Evaluation, Postmarketing Surveillance, Risk Evaluation and Mitigation Strategies, REMS, Target Product Profiles, Scientific Assessment and Review, …

103 similar entities Type: SMB Activities: biotech deeptech martech regtech Technologies: Synthetic Biology

End-to-end clinical, regulatory & competitive intelligence helping pharma, biotech & CROs navigate trials and compliance At Citeline (a Norstella company), we are a global leader in clinical trial intelligence, data, and insights for the life sciences and pharmaceutical industries. We help organizations accelerate drug development, enhance transparency, and improve clinical outcomes through real‐time, decision‐ready intelligence across the entire drug lifecycle. Our solutions provide one of the most comprehensive and continuously updated views of global clinical trials, investigators, sites, pipelines, regulatory requirements, and competitive landscapes—enhanced with AI, curated datasets, and expert analysis. This empowers pharma, biotech, and CRO partners to plan …

70 similar entities Type: SMB Activities: deeptech healthtech Technologies: Data Analytics

Pragati Healthcare India is a global exporter and distributor of Anti-cancer, Diabetes, Hepatitis, Cardiac, Sexual Health, HIV, Ophthalmic and OTC products. Our family has been into pharmaceutical distribution for over 50 years now and have significant presence in UK & Hong Kong. We have direct tie ups with reputed pharma companies like Pfizer, AstraZeneca, Novartis, Novo Nordisk, Eli Lilly, Bayer, Abbott, Boehringer Ingelheim, Sanofi, Sun Pharma, Natco, Cipla, Lupin, Intas and others. For other companies, we source from vendors after careful research about their repute and history. Cancer Medicines Exporter, Unlicensed Medicines, Parallel Exports, Europe Medicine Supplier, Named Patient Medication, …

60 similar entities Type: Startup Activities: biotech deeptech

Our mission is to accelerate tomorrow’s treatment together MonolixSuite is a powerful, fast, and easy-to-use suite of applications designed for model-informed drug development. With fully interoperable tools for non-compartmental analysis, bioequivalence, population PK/PD modeling, and clinical trial simulations, MonolixSuite accelerates decision-making. It drives smarter, faster, and more effective drug development to improve patient outcomes worldwide Statistics, Pharmacometrics, Modelling and Simulation, Business software, Clinical trials, PKPD, and Non-compartmental analysis

115 similar entities Type: Startup Activities: biotech deeptech it services Technologies: Data Analytics

Drug discovery with cutting-edge AI technology We’re pioneering the use of AI and shaping the future in drug discovery, significantly cutting costs and development times. Our unique AI algorithms have generated novel drug candidates and identified enhancements for existing therapies more efficiently than traditional methods, setting us apart in the competitive landscape. Artificial Intelligence, Data Science, Health, Medicines, and Drug development

118 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Creativ-Ceutical provides strategic pricing, market access and health economics consulting in life sciences. We provide both the strategic advice and the technical services to deliver results that meet your expectations. We have broad experience in the areas of central nervous system (CNS), oncology, vaccines, metabolic/cardiovascular diseases, and rare diseases. These are complex and developing fields, where treatment paradigms are in constant evolution and where clinical and economic issues require rigorous analysis to determine the best therapeutic choices. This experience allows us to address the most complex challenges and to anticipate pricing and market access issues that will arise in other …

141 similar entities Type: SMB Startup Activities: biotech deeptech Technologies: Synthetic Biology

Focusing on Resistance in Antibiotic Development Qpex Biopharma, Inc. a Shionogi Group Company, is a resistance-focused infectious disease company on a mission to make both a dramatic and sustainable improvement in patient care. Leveraging a multi-faceted approach and a deep understanding of drug resistance mechanisms, we are creating novel products and development. strategies that overcome multi-drug resistance. We are advancing a robust portfolio of treatments that will bring innovation to antibiotic development and deliver the right treatments to the right patients in the right settings. During the previous decade, our team brought 4 antibiotic products to regulatory approvals, with an …

79 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

NEW FRONTIERS IN NEUROSCIENCE Neurentis PLC is a late-clinical stage UK specialty pharma company, focusing on neuroscience and specialising in the development of novel treatments for mental health and other neurological and psychiatric diseases. Our product pipeline is balanced with an advanced lead drug for the treatment of Treatment-Resistant Depression (TRD) in the last stages of drug development as well as earlier stage drug candidates in collaboration with research institutions and other companies. The company is run by experienced ex-pharma industry executives, with more than 35 years’ experience in the sector each. The company’s low-risk commercial strategy is to commercialize …

382 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

AI-driven Personalized Medicine for Cancer Care ImpriMed, founded in 2017 in Silicon Valley, is a leading precision medicine startup revolutionizing cancer treatment with artificial intelligence. The company’s pioneering drug response prediction technology helps reduce costs, accelerate treatment, enhance efficacy, and improve the quality of life for patients. To date, the company’s technology has been deployed across more than 40 U.S. states, and 22,000+ canine and feline blood cancer tests have been performed as of 2026. ImpriMed is now poised to extend its groundbreaking AI-driven approach to human healthcare, redefining the future of oncology treatment with personalized, effective solutions. For additional …

191 similar entities Type: Startup Activities: pettech deeptech biotech Technologies: A.I.

Anything is Druggable - with Quantum Accuracy Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. We leverage our technologies and expertise to advance 7 fully owned drug discovery programs focusing on cancer resistance and escapement, a growing concern in aging populations, and chronic inflammatory diseases. We also co-develop programs with academia and pharmaceutical partners. Our proprietary ATLAS drug discovery platform unites our technologies based on 30 years of research from renowned scientists and founders, Louis Lagardère (Sorbonne University and CNRS), Matthieu Montes (CNAM), Jean-Philip Piquemal (Sorbonne …

284 similar entities Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We represent the innovative pharmaceutical industry globally, with a focus on innovation, equitable access, and ethics. IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere. To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health. Biopharmaceuticals, …

99 similar entities Type: NGO, Think-tanks, Ed, & Culture Startup Activities: biotech deeptech Technologies: Synthetic Biology

AI-native pharmaceutical company We are an AI-native pharmaceutical company transforming scientific innovation from Africa and the UK into high-impact global health solutions. By combining cutting-edge artificial intelligence with regional biomedical expertise, we accelerate drug discovery and development—turning underutilized insights into scalable therapeutic assets. Our mission is to close the innovation gap, reduce R&D timelines, and deliver next-generation treatments to patients worldwide.

184 similar entities Type: Startup Activities: biotech healthtech Technologies: A.I.

www.xspraypharma.com Xspray Pharma (Nasdaq Stockholm: XSPRAY) aims to improve patients’ quality of life by developing and producing pharmaceuticals, based on world leading technology and deep industry expertise. Xspray Pharma uses its innovative, patented, and scalable technology to develop improved versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer. The company has several product candidates in clinical development and a wide pipeline of potential candidates. The proven HyNap technology allows the company to gain entry before the secondary patents expire and can thereby benefit patients rapidly. Xspray Pharma's first product XS0004 dasatinib is pending FDA approval …

76 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Transforming science into drug success stories Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly.​ Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty.​ We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible. Translational research, Biotechnology, Pharmaceuticals, …

225 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Pyramid studio embodies an unique way of leading therapeutic innovation to fuel the pipeline of pharmaceutical companies Pyramid Studio is a First-of-its-Kind venture builder dedicated to fuel the pipeline of pharmaceutical companies Pyramid Studio embodies a new way of leading therapeutic innovation through a unique build-to-buy model. Our mission is to bridge the gap for pharmaceutical companies seeking access to breakthrough innovations and delivering new therapies to patients. In practice, our team identifies and rigorously selects groundbreaking innovations from top academic teams across Europe. We collaborate closely with our Pharma partners to co-develop and co-finance these programs, ultimately delivering IND-ready …

293 similar entities Type: Incubators & VCs Startup Activities: deeptech biotech Technologies: Synthetic Biology

Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases

519 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

The extension of the pharmacist to support good nursing practices DrugOptimal offers software, an extension of the pharmacist, deployable in service to caregivers in order to avoid physicochemical drug incompatibilities (IPC) by detecting risks on the prescription and proposing administration solutions to avoid them. Database of 105,000 couples, validated, and developed from a compilation of 22,000 scientific articles, an IPC prediction model by AI (+4000 physico-chemical parameters per couple) and our own analytical chemistry research laboratory (dedicated high-throughput platform allowing the analysis of more than 1000 samples per day). Our scope of action: - Injectable drugs: support for the choice …

71 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology SaaS

The Euro/Global Platform for Drug Repurposing REPO4EU is the Euro/Global Platform for Drug Repurposing - from imprecise drug therapy to AI-powered precision medicine. Should you need any help in searching for bioinformatics support for an unmet medical need, a registered compound or a specific mechanism; exploring your freedom to operate or a patenting strategy or regulatory advice; liaising with a business partner, setting up a clinical trial test site for phase I-III or crafting a business plan... we have the experts and global experience to help and work with you! bioinformatics, drug repurposing, artificial intelligence, and pharmacology

214 similar entities Type: Startup Activities: biotech Technologies: SaaS

Creation and implementation of innovative therapeutic solutions derived from cannabinoid biomolecules. Since the entry into common law of medical cannabis in September 2023, the development of new drugs has been at the center of the pharmaceutical industry's concerns. Chenevia is a French Biotech startup, financed by Breton investors, subsidized by the Brittany Region, supported by Crédit Agricole via the Village by CA Morbihan accelerator and active member of Santé France Cannabis (privileged consultant to the Government on the regulation of medical cannabis). The 3 co-founders have skills combining technique, pharmaceutical expertise and compliance with regulatory constraints. We are committed to …

140 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Digital bio-solutions designed to support the development of biomedicines and optimize their prescription. mYXpression is an innovative French company positioned in the field of health innovation. The company, specialized in R&D, develops innovative tools to assist in the prescription of biomedicines. Its first tool, the RITI® RA test, provides a personalized report specific to the patient by indicating an efficacy score for each biotherapy. This brand new approach provides numerous useful insights to the doctor by assisting in the prescription of biotherapy in order to increase the patient's chances of remission. bio-numérique, innovation technologique, big data, bio-technologie , biotherapie, intelligence …

189 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I.

Innovating to Enhance Quality of Life Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes. Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, and Neurology

616 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

we develop for patients Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If your university …

85 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We personalise prescribing by matching medication to patient data and DNA. Empowering doctors to say 'this drug is not for everyone, but it is for you. Founded in 2012, we are a London based start-up committed to personalising medicine. To achieve this, we've built a strong team with extensive expertise in pharmacogenetics, pharmacology, big data analytics, business strategy, the NHS and creative design. Pharmacogenetics, Personalised Medicine, Bioinformatics, CPOE, Big Data, and Design

101 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Data Analytics

SynapCon develops & distributes software for clinical trials, making the process faster, better and more cost-effective. We digitise the entire process of pharma, biotech or medtech clinical trials, making them easier to manage, much faster and much more cost effective! Saving millions of patients and healthcare dollars through better access to medicines and medical devices worldwide. AUDITED QUALIFIED SUPPLIER 2022/2023. Thanks to the EMA's recent Notice to Sponsors, there has never been a better time for our product to demonstrate its capabilities. Clinical Research, EU-GDPR, Compliance Management, Artificial Intelligence, CROIT (Clinical Research Operations Information Technology), Consultancy (Medical Development and IT), …

376 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I. A.I. - Machine Learning

Predicting clinical trial outcomes in realtime Clinical trials are currently unable to stop at the right time. Presentient cuts clinical trial durations in half by automatically detecting when trials should stop early. The cost of bringing a new drug to market has doubled every 9 years since the 1950s. Now it’s $1bn+. Our mission in the next 4-5 years, is to be helping accelerate clinical trials across all clinical specialties and across the globe. This is in order to meaningfully increase the flow of critical new medicines to patients in need. Clinical trials and Data analytics

73 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics A.I.

The First Cell-Centered Computational Model of Human Disease CytoReason is a tech company transforming biopharma’s decision-making from trial and error to data-driven using an AI Platform of computational disease models. With its extensive database of public and proprietary data, the company maps human diseases – tissue by tissue and cell by cell. Researchers of all levels rely on CytoReason’s technology to make data-driven decisions across the drug development life cycle. Scientists can identify potential targets, prioritize indications, and stratify patient populations. Program leaders can compare drugs across multiple diseases or multiple drugs within a single disease. C-level executives can gain …

91 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

Your local champion and alternative partner Newbury Pharmaceuticals was founded in 2020 by Swedish Karl Karlsson. We are rapidly growing and offer a product portfolio of specialty pharma medicines with focus on the Scandinavian markets. The portfolio strategy includes niche and value-added small molecules, products based on peptide technology as well as biosimilars in a variety of therapeutic categories. The portfolio consists of pharmaceuticals from several therapeutic areas with oncology, rare diseases and neurology representing more than 70 percent. The company was listed on Nasdaq First North, February 2022.

98 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Let's bring medicines to the world, because the world is waiting NDA Group is the regulatory powerhouse of SSI Strategy. For more than 25 years we’ve leveraged our extensive experience and global network to help you optimize your regulatory strategies, expedite filings, and secure successful approvals in key markets worldwide. By integrating our regulatory proficiency with SSI Strategy's strategic capabilities in clinical development, medical affairs and commercial planning, we provide biotech companies with a holistic solution that maximizes the value of their assets and ensures timely access to innovative therapies. We understand that bringing a new therapy to market is …

95 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Zerion Pharma is a pharmaceutical company transforming the landscape for formulation of poorly soluble drugs Zerion is a pharmaceutical company transforming the pharmaceutical landscape for formulation of poorly soluble drugs that are currently not reaching their therapeutic potential. Through the use of our proprietary formulation platform, we aim to develop new treatment options for patients across all small molecule therapy areas. We are focused on improving existing drug products by building an internal pipeline, while partnering with originators to enable their early stage drug molecules, striving to improve the lives of patients around the world. Pharmaceuticals, Formulation, and Drug delivery

184 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unlocking the potential of cannabis medicines for those who need it. Unlocking the potential of cannabis medicines for those who need it. Our Market Access Team launches medical cannabis producers'​ businesses into new markets to create long-term value for them. Our R&D Team creates new technologies for medical cannabis producers to create better, cost-effective, accessible medicines for patients. By combining our strengths as scientists, technologists, and commercial strategists, we create game-changing Intellectual Property that will transform the fastest growing industry in the world, medical cannabis. Find all our links at: https://growgroup.komi.io Cannabis Biotech, Medical Cannabis, Research & Development, Technology, Biotech, …

61 similar entities Type: Startup Activities: deeptech healthtech manufacturing

Your CDMO for API solutions since 1970 | Our excellence, your trust #OEYT At Seratec, APIs are more than a science. They are a passion. Entrepreneurs in pharmaceutical chemistry since 1970, we produce active pharmaceutical ingredients (APIs) for the treatment of rare and orphan diseases. Drawing on internationally recognized French know-how, we design, develop, produce and register files for pharmacologically active molecules with the American (FDA), European (EMA) and national (ANSM) drug agencies. To offer the best services, we also ensure the production of APIs according to quality standards known as Good Manufacturing Practices (GMP 2 or cGMP). The pharmaceutical …

121 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

As a member of ONO Group, Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit www.deciphera.com.

157 similar entities Type: SMB Activities: biotech deeptech Technologies: SaaS

Next-generation drug development company Lindus Therapeutics is a next-generation drug development company. We advance portfolios of in-licensed assets, pairing our own asset identification and selection capability with an integrated clinical trial execution platform. Domain experts work hand in glove with proprietary AI systems, so we and our partners reach value inflection points faster and more efficiently than the industry standard. Lindus is backed by investors and advisors including Peter Thiel and Bob Langer. clinical development, clinical trials, and drug development

83 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Data Analytics

Centre d'Etudes Biologiques et Pharmaceutiques OUR MISSION: Provide analytical support for all product development phases (human & veterinary medicines + Medical Device) with: Consulting and expertise Formulation development support Analytical method development and validation Stability studies QC testing Veterinary pre-clinical and clinical studies Analyse pharmaceutique, Pharmaceutical analysis, Contract Research Organization (CRO), Développement analytique, Contrôle qualité pharmaceutique, Quality control (QC), Method development, Analytical method validation, ICH guidelines, ICH Q2 / ICH Q14, Validation analytique, Transfert de méthodes, Biopharmaceuticals, Small molecules, sterile products, Vaccins, Stability studies, Regulatory affairs, GMP compliance, GLP compliance, CCIT (Container Closure Integrity Testing), Extractables & Leachables, Elemental impurities …

135 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Galenix, a Key pharmaceutical R&D partner, helps you to reduce your timeline by offering innovative solutions DRUG DELIVERY SOLUTIONS - DRUG PRODUCT DEVELOPMENT - LICENSING-OUT OPPORTUNITIES Galenix provides a range of full R&D pharmaceutical services and Drug Delivery Solutions to health companies for fast access of their products on the market. ●●● From the sourcing of the API through the Drug Product development process, including preformulation, formulation, to clinical supplies, quality control, ICH stabilities and regulatory dossier submission for Europe and US FDA registration. Galenix provides its customers drug products “ready to launch” holding a Marketing Authorization. ●●● Galenix Innovations …

66 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Causeway Sensors uses nanotechnology to provide better candidate selection during drug development. The company spun-out after years of high-impact research at Queen's University Belfast. Our unique nanochip platform brings real-time, label-free kinetic analysis to areas of biotherapeutic production where such data cannot currently be collected. More data at critical points of production helps pharma companies ensure that only the best drug candidates progress to clinical trials. The platform can be incorporated into a multitude of form factors, ranging from a high-throughput screening instrument to an in-line cell culture monitoring tool. Biosensing, Protein - Protein Interactions, Binding Kinetics, Biotechnology, Biotherapeutics, Antibody …

422 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics Synthetic Biology

Tanabe Pharma America, Inc., previously Mitsubishi Tanabe Pharma America, Inc., was launched in 2016 as a wholly-owned subsidiary of what is now Tanabe Pharma Corporation – one of the world’s oldest pharmaceutical companies. Driving scientific discovery and innovation is at the center of everything we do, and it’s more than just a passion – it’s a commitment. Tanabe Pharma America is charged with developing and advancing our pipeline as well as commercializing approved pharmaceutical products in North America. Please see our LinkedIn community guidelines here: http://www.us.tanabe-pharma.com/pdf/LinkedIn-Community-Guidelines.pdf pharmaceutical products, rare disease, innovation, research and development, and global business

167 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: IoT

Innovating to Disrupt Cancer Treatment Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in global clinical trials. For more information, please visit our website, or call us +33 4 91 26 99 50. Liver, Oncology, Clinical Development, Preclinical Development, Discovery, Research & Development, Intellectual Property, Drug Development, and Small Molecule

634 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Novalix is a premier drug discovery CRO Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry, Chemical process research, DMPK, and ADME

515 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Aureus Sciences focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process. Over the course of 10 years and with a significant investment, the Company has developed a unique Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases. Using this platform the Company provides best-in-class, scientific databases and associated software applications for use by researcher involved in the drug discovery and development process.The company's range of products includes …

150 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Smarter Tech, Faster Therapies We are dedicated to advancing access to numerous technological innovations, elevating the quality, rigor, and reliability of clinical research rooted in the scientific method. Our commitment is to be instrumental in accelerating drug development, supporting pharmaceutical and biotechnology companies to bring therapies to patients swiftly and efficiently. AI, Machine Learning, Technology, Data, and Adaptive Clinical Trials

252 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics

In-silico drug development for API small molecules ⚛️ Our AI-driven platform fuses quantum physics, machine learning, and high-performance cloud computing to simulate crystal formation and address one of pharma’s most critical challenges: polymorphism. The impact? Weeks instead of months. Certainty over guesswork. Global Pharmaceutical leaders trust us to reduce risk, accelerate timelines, and boost the success rate of new drugs. Backed by Enterprise Ireland, the EIC Accelerator, and strategic partners like Viridien (formerly CGG), we’re scaling fast. Follow along as we change how the world brings medicines to life. Computational Chemistry, Molecular Modeling, and AI Drug Development

149 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning

The leader in Prescription Digital Therapeutics Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first …

59 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Our Experience, Your Success: A full-service IVD CRO partner delivering clinical, regulatory and quality expertise For over three decades, MDC has been the expert CRO partner for diagnostic innovators bringing critical tests to market. We understand and can anticipate challenges along the way. That is why we identify obstacles early, minimize risks with pristine execution, and guide your team through the essential steps to market authorization. Whether you need clinical, regulatory, or quality support, we develop and deliver tailored solutions to meet your needs. We have delivered over 150 successful FDA submissions and managed more than 100 clinical studies across …

177 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology